(Total Views: 190)
Posted On: 06/03/2022 2:45:51 PM
Post# of 126865

$IMMP News Article - Immutep Reports Positive Overall Response Rate in its Phase II Clinical Trial in 1st line NSCLC for PD-L1 All-Comers https://marketwirenews.com/news-releases/immu...24847.html


My Twitter: WhyteStocks